138 related articles for article (PubMed ID: 25899113)
1. [Postoperative morbidities after modified posterior pelvic exenteration for ovarian cancer].
Emin L; Meeus P; Beurrier F; Ferraioli D; Carrabin N; Ray-Coquard I; Treilleux I; Chopin N
Gynecol Obstet Fertil; 2015 May; 43(5):342-7. PubMed ID: 25899113
[TBL] [Abstract][Full Text] [Related]
2. Modified posterior pelvic exenteration for advanced ovarian malignancies: a single-institution study of 35 cases.
Minar L; Felsinger M; Rovny I; Zlamal F; Bienertova-Vasku J; Jandakova E
Acta Obstet Gynecol Scand; 2017 Sep; 96(9):1136-1143. PubMed ID: 28585317
[TBL] [Abstract][Full Text] [Related]
3. Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: Clinical and functional outcome.
Berretta R; Marchesi F; Volpi L; Ricotta G; Monica M; Sozzi G; Di Serio M; Mautone D
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):346-50. PubMed ID: 27343313
[TBL] [Abstract][Full Text] [Related]
4. Modified posterior exenteration for ovarian cancer.
Eisenkop SM; Nalick RH; Teng NN
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):879-85. PubMed ID: 1923216
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic tumor spreading in primary ovarian cancer with modified posterior exenteration.
Kato K; Nishikimi K; Tate S; Kiyokawa T; Shozu M
World J Surg Oncol; 2015 Jul; 13():230. PubMed ID: 26228239
[TBL] [Abstract][Full Text] [Related]
6. Comparison of morbidity and survival between primary and interval cytoreductive surgery in patients after modified posterior pelvic exenteration for advanced ovarian cancer.
Revaux A; Rouzier R; Ballester M; Selle F; Daraï E; Chéreau E
Int J Gynecol Cancer; 2012 Oct; 22(8):1349-54. PubMed ID: 22954783
[TBL] [Abstract][Full Text] [Related]
7. Modified posterior pelvic exenteration for ovarian cancer.
Houvenaeghel G; Gutowski M; Buttarelli M; Cuisenier J; Narducci F; Dalle C; Ferron G; Morice P; Meeus P; Stockle E; Bannier M; Lambaudie E; Rouanet P; Fraisse J; Leblanc E; Dauplat J; Querleu D; Martel P; Castaigne D
Int J Gynecol Cancer; 2009 Jul; 19(5):968-73. PubMed ID: 19574794
[TBL] [Abstract][Full Text] [Related]
8. Modified posterior pelvic exenteration with pelvic side-wall resection requiring both intestinal and urinary reconstruction during surgery for ovarian cancer.
Kato K; Omi M; Fusegi A; Takeshima N
Gynecol Oncol; 2019 Oct; 155(1):172-173. PubMed ID: 31351675
[TBL] [Abstract][Full Text] [Related]
9. Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery.
Benedetti Panici P; Di Donato V; Fischetti M; Casorelli A; Perniola G; Musella A; Marchetti C; Palaia I; Berloco P; Muzii L
Gynecol Oncol; 2015 Jun; 137(3):406-11. PubMed ID: 25824857
[TBL] [Abstract][Full Text] [Related]
10. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
[TBL] [Abstract][Full Text] [Related]
11. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer.
Berretta R; Capozzi VA; Sozzi G; Volpi L; Ceni V; Melpignano M; Giordano G; Marchesi F; Monica M; Di Serio M; Riccò M; Ceccaroni M
Arch Gynecol Obstet; 2018 Apr; 297(4):997-1004. PubMed ID: 29380107
[TBL] [Abstract][Full Text] [Related]
13. [Super radical surgery of advanced ovarian cancers (stages III and IV)].
Michel G; Castaigne D; Morice P; Lhommé C; Duviliard P
Contracept Fertil Sex; 1997 Jun; 25(6):V-XI. PubMed ID: 9280543
[No Abstract] [Full Text] [Related]
14. Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes.
Houvenaeghel G; de Nonneville A; Blache G; Buttarelli M; Jauffret C; Mokart D; Sabiani L
J Gynecol Oncol; 2022 May; 33(3):e31. PubMed ID: 35320883
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
[TBL] [Abstract][Full Text] [Related]
17. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pelvic posterior exenteration in the management of advanced-stage ovarian cancer.
Tixier H; Fraisse J; Chauffert B; Mayer F; Causeret S; Loustalot C; Deville C; Bonnetain F; Sagot P; Douvier S; Cuisenier J
Arch Gynecol Obstet; 2010 Mar; 281(3):505-10. PubMed ID: 19847452
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Transanal Drainage Tube Placement After Modified Posterior Pelvic Exenteration for Primary Ovarian Cancer.
Kato K; Omatsu K; Matoda M; Nomura H; Okamoto S; Kanao H; Utsugi K; Takeshima N
Int J Gynecol Cancer; 2018 Feb; 28(2):220-225. PubMed ID: 29240601
[TBL] [Abstract][Full Text] [Related]
20. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
